Upon suspension of the trading of its Common Stock on Nasdaq, the Company expects that its Common Stock will be quoted under ...

Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73 (95% confidence interval, 0.56 to 0.96) compared to ...

The administration of U.S. President Donald Trump is making life difficult for academics and scientific researchers. Many are looking to leave the country as a result. We spoke with four of them.

While incidence of community-associated and healthcare-associated community-onset MRSA bacteremia declined during the ...

When you buy something by clicking links within this article, we may earn a small commission, but it never affects the ...

Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

Kimera Labs, Inc., the pioneer in therapeutic exosome biotechnology, is proud to announce its selection as a semifinalist in ...